Humana (HUM) Asset Writedowns and Impairment (2022 - 2026)

Humana (HUM) has 5 years of Asset Writedowns and Impairment data on file, last reported at $2.0 million in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment fell 77.78% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $121.0 million, a 42.11% decrease from a year earlier, with the FY2025 full-year figure at $128.0 million, down 36.0% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $2.0 million, down from $114.0 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for HUM reached as high as $200.0 million in Q4 2024 and fell as low as -$144.0 million in Q4 2022.
• Historically, Asset Writedowns and Impairment has averaged $28.5 million across 5 years, with a median of $31.0 million in 2023.
• Across the five-year window, Asset Writedowns and Impairment surged 675.0% in 2023 and tumbled 77.78% in 2026, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at -$144.0 million in 2022, then soared by 141.67% to $60.0 million in 2023, then surged by 233.33% to $200.0 million in 2024, then tumbled by 43.0% to $114.0 million in 2025, then slumped by 98.25% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $2.0 million in Q1 2026, $114.0 million in Q4 2025, and -$27.0 million in Q3 2025.